Serveur d'exploration sur les pandémies grippales - Exploration (Accueil)

Index « AbsEn.i » - entrée « phase »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
pharynx < phase < phased  Facettes :

List of bibliographic references indexed by phase

Number of relevant bibliographic references: 224.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000288 (2019) Jun Cai [République populaire de Chine] ; Bo Xu [République populaire de Chine] ; Karen Kie Yan Chan [République populaire de Chine] ; Xueying Zhang ; Bing Zhang ; Ziyue Chen ; Bing Xu [République populaire de Chine]Roles of Different Transport Modes in the Spatial Spread of the 2009 Influenza A(H1N1) Pandemic in Mainland China
000351 (2019) Maaike Droogers [Pays-Bas] ; Massimo Ciotti [Suède] ; Peter Kreidl [Autriche] ; Angeliki Melidou [Suède] ; Pasi Penttinen [Suède] ; Chloe Sellwood [Royaume-Uni] ; Svetla Tsolova [Suède] ; René Snacken [Suède]European Pandemic Influenza Preparedness Planning: A Review of National Plans, July 2016.
000554 (2018) B. HenryCanadian Pandemic Influenza Preparedness: Health sector planning guidance
000636 (2017) Hélène Pasquini-Descomps [Suisse] ; Nathalie Brender [Suisse] ; David Maradan [Suisse]Value for Money in H1N1 Influenza: A Systematic Review of the Cost-Effectiveness of Pandemic Interventions.
000658 (2017) Romuald Lango [Pologne] ; Zbigniew Szkulmowski ; Dariusz Maciejewski ; Andrzej Sosnowski ; Krzysztof KuszaRevised protocol of extracorporeal membrane oxygenation (ECMO) therapy in severe ARDS. Recommendations of the Veno-venous ECMO Expert Panel appointed in February 2016 by the national consultant on anesthesiology and intensive care.
000673 (2017) O. Mgbere [États-Unis] ; K. Ngo [États-Unis] ; S. Khuwaja [États-Unis] ; M. Mouzoon [États-Unis] ; A. Greisinger [États-Unis] ; R. Arafat [États-Unis] ; J. Markee [États-Unis]Pandemic-related health behavior: repeat episodes of influenza-like illness related to the 2009 H1N1 influenza pandemic.
000723 (2017) Valentina Marziano [Italie] ; Andrea Pugliese [Italie] ; Stefano Merler [Italie] ; Marco Ajelli [Italie, États-Unis]Detecting a Surprisingly Low Transmission Distance in the Early Phase of the 2009 Influenza Pandemic
000748 (2017) Kinnera E. Chada [États-Unis] ; Richard Forshee [États-Unis] ; Hana Golding [États-Unis] ; Steven Anderson [États-Unis] ; Hong Yang [États-Unis]A systematic review and meta-analysis of cross-reactivity of antibodies induced by oil-in-water emulsion adjuvanted influenza H5N1 virus monovalent vaccines.
000825 (2016) George Gachara [Kenya] ; Samuel Symekher [Kenya] ; Michael Otieno [Kenya] ; Japheth Magana [Kenya] ; Benjamin Opot [Kenya] ; Wallace Bulimo [Kenya]Whole genome characterization of human influenza A(H1N1)pdm09 viruses isolated from Kenya during the 2009 pandemic.
000826 (2016) Markus Vogel ; Sebastian Grund ; Subashjung Pandey ; Ertan Mayatepek ; Horst Schroten ; Tobias Tenenbaum ; Ortwin AdamsWhat We Have Learned from the Influenza A pH1N1 2009/10 Pandemic: High Clinical Impact of Human Metapneumovirus and Respiratory Syncytial Virus in Hospitalized Pediatric Patients.
000833 (2016) Evelot Duijzer [Pays-Bas] ; Willem Van Jaarsveld [Pays-Bas] ; Jacco Wallinga [Pays-Bas] ; Rommert Dekker [Pays-Bas]The most efficient critical vaccination coverage and its equivalence with maximizing the herd effect.
000882 (2016) David L. Gordon [Australie] ; Dimitar Sajkov [Australie] ; Yoshikazu Honda-Okubo [Australie] ; Samuel H. Wilks [Royaume-Uni] ; Malet Aban [Australie] ; Ian G. Barr [Australie] ; Nikolai Petrovsky [Australie]Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant
000885 (2016) Leora R. Feldstein [États-Unis] ; Laura Matrajt [États-Unis] ; M. Elizabeth Halloran [États-Unis] ; Wendy A. Keitel [États-Unis] ; Ira M. Longini [États-Unis]Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies
000904 (2016) Rahnuma Wahid [États-Unis] ; Renee Holt [États-Unis] ; Richard Hjorth [États-Unis] ; Francesco Berlanda Scorza [États-Unis]Chemistry, manufacturing and control (CMC) and clinical trial technical support for influenza vaccine manufacturers.
000911 (2016) Emi Takashita [Japon] ; Miho Ejima [Japon] ; Rie Ogawa [Japon] ; Seiichiro Fujisaki [Japon] ; Gabriele Neumann [États-Unis] ; Yousuke Furuta [Japon] ; Yoshihiro Kawaoka [Japon] ; Masato Tashiro [Japon] ; Takato Odagiri [Japon]Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir.
000A53 (2015) Marie Leoz [France] ; Felix Feyertag [Royaume-Uni] ; Anfumbom Kfutwah [Cameroun] ; Philippe Mauclère ; Guillaume Lachenal [France] ; Florence Damond [France] ; Fabienne De Oliveira [France] ; Veronique Lemée [France] ; Francois Simon [France] ; David Robertson [Royaume-Uni] ; Jean-Christophe Plantier [France]The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon
000A98 (2015) Olusegun Steven Ayodele Oluwole [Nigeria]Seasonal Influenza Epidemics and El Niños
000B23 (2015) Nicola L. Bird [Australie] ; Matthew R. Olson [Australie] ; Aeron C. Hurt [Australie] ; Christine M. Oshansky [États-Unis] ; Ding Yuan Oh [Australie] ; Patrick C. Reading [Australie] ; Brendon Y. Chua [Australie] ; Yilun Sun [États-Unis] ; Li Tang [États-Unis] ; Andreas Handel [États-Unis] ; David C. Jackson [Australie] ; Stephen J. Turner [Australie] ; Paul G. Thomas [États-Unis] ; Katherine Kedzierska [Australie]Oseltamivir Prophylaxis Reduces Inflammation and Facilitates Establishment of Cross-Strain Protective T Cell Memory to Influenza Viruses
000B57 (2015) Kristin G.-I. Mohn [Norvège] ; Rebecca Jane Cox [Norvège] ; Gro Tunheim [Norvège] ; Jan Erik Berdal [Norvège] ; Anna Germundsson Hauge [Norvège] ; Sne Jul-Larsen [Norvège] ; Bjoern Peters [États-Unis] ; Fredrik Oftung [Norvège] ; Christine Monceyron Jonassen [Norvège] ; Siri Mjaaland [Norvège]Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway
000C21 (2015) Adiveppa S. Kadi [Inde] ; Shivakumari R. Avaradi [Inde]A Bayesian Inferential Approach to Quantify the Transmission Intensity of Disease Outbreak
000D76 (2014) Amali E. Samarasinghe [États-Unis] ; Stacie N. Woolard [États-Unis] ; Kelli L. Boyd [États-Unis] ; Scott A. Hoselton [États-Unis] ; Jane M. Schuh [États-Unis] ; Jonathan A. Mccullers [États-Unis]The immune profile associated with acute allergic asthma accelerates clearance of influenza virus

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "phase" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "phase" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    phase
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021